ArticleClinical Medicine Insights. Oncology2026
Development of Nomogram for Predicting Postoperative Progression Risk in High-Risk Thymoma and Thymic Carcinoma Utilizing Clinical and Preoperative CT Features.
Article in Clinical Medicine Insights. Oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Computed tomography (CT) features and clinical characteristics have been shown in recent studies to be effective predictive indicators for risk stratification of thymic epithelial tumors. High-risk thymoma and thymic carcinoma (HRT-TC) are highly aggressive and are associated with poor prognoses. The aim of this study is to evaluate the predictive value of CT features and clinical characteristics to assess postoperative progression in patients with HRT-TC. Methods: Clinical and enhanced CT data were retrospectively collected from patients who underwent HRT-TC surgery between June 1, 2012, and June 1, 2022. A univariate Cox regression analysis was conducted to identify the risk factors associated with postoperative progression. A multivariate Cox regression analysis was then used to determine the independent risk factors. Three-year and 5-year single-factor models as well as multifactorial combined models were then constructed based on the results of these analyses to assess their efficacy, accuracy, and net benefit. The best-performing model was selected to create a nomogram for a consistency assessment. Results: A total of 215 patients were included in the study. The multivariate Cox regression analysis revealed that independent prognostic factors that influenced postoperative progression were the tumor length (hazard ratio [HR] = 1.027; 95% confidence interval [CI] = 1.004-1.049, Conclusions: A nomogram based on clinical and CT features provided effective predictions of progression following HRT-TC. This prognostic tool holds significant value for clinicians to guide therapeutic decisions and personalize survival assessments.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.